Quality of Life Research

, Volume 12, Issue 2, pp 103–115 | Cite as

Aspects of quality of life through end-stage renal disease

  • Gabriele Helga Franke
  • Jens Reimer
  • Thomas Philipp
  • Uwe Heemann
Article

Abstract

This study was conducted to explore differentiated aspects of quality of life (QoL) throughout the course of end-stage renal disease (ESRD) with special regard to kidney transplantation (KTX). In detail two questions were addressed: (1) does social support change over time? and (2) is psychological distress a predictor of generic and disease-specific QoL? Two groups of ESRD-patients were investigated twice with different psychodiagnostic inventories. At t0 the Brief Symptom Inventory (BSI) and a validated German Social Support Questionnaire were administered. At t1 social support as well as generic and disease-specific QoL were investigated (SF-36, End-Stage Renal Disease Symptom Checklist-Transplantation Module [ESRD-SCLTM]). Group A consisted of 80 patients treated by dialysis while on the waiting list for transplantation when investigated at t0 and was followed after successful transplantation at t1. Group B consisted of 222 patients investigated twice after successful KTX. Groups A and B did not differ with respect to clinical data and comorbidity, except for stronger immunosuppression in transplanted patients of group A. Group A demonstrated a statistically significant (5% explanation of variance) increased satisfaction with social support after KTX, whereas group B reported a decrease. The psychological distress at t0 predicted QoL at t1 in both groups (2–13% explanation of variance of SF-36, ESRD-SCLTM-scores). High psychological distress on dialysis and after KTX is a predictor for low long-term QoL.

End-stage renal disease Quality of life Transplantation 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Frei U, Schober-Halstenberg HJ, the QuaSi-Niere Task Group for Quality Assurance in Renal Replacement Therapy. Annual report of the German Renal Registry 1998. Nephrol Dial Transplant 1999; 14: 1085–1090.Google Scholar
  2. 2.
    De-Nour AK, Brickman AL. Determining the quality of life in the renal replacement therapies. In Spilker B (ed.), Quality of Life and Pharma coeconomics in Clinical Trials, Philadelphia, Lippincott-Raven, 1996; 953–960.Google Scholar
  3. 3.
    Gritsch HA. Renal transplantation-improving the quality of life (editorial). J Urol 1996; 56: 889.Google Scholar
  4. 4.
    McCauley J, Irish W, Thompson L, et al. Factors determining the rate of referral, transplantation, and survival on dialysis in women with ESRD. Am J Kidney Dis 1997; 30: 739–748.Google Scholar
  5. 5.
    Burton PR, Walls J. Selection-adjusted comparison of life-expectancy of patients on continuous ambulatory peritoneal dialysis, haemodialysis, and renal transplantation. Lancet 1987; 1: 1115–1119.Google Scholar
  6. 6.
    Hutchinson TA, Thomas DC, Lemieux JC, Harvey CE. Prognostically controlled comparison of dialysis and renal transplantation. Kidney Int 1984; 26: 44–51.Google Scholar
  7. 7.
    Vollmer WM, Wahl PW, Blagg CR. Survival with dialysis and transplantation in patients with end-stage renal disease. N Engl J Med 1983; 308: 1553–1558.Google Scholar
  8. 8.
    Garcia G, Deddens JA, D'Achiardi-Rey R. Results of treatment in patients with end-stage renal disease: A multivariate analysis of risk factors and survival in 341 successive patients. J Kidney Dis 1985;5: 10–18.Google Scholar
  9. 9.
    Medin C, Elinder CG, Hylander B, Blom B, Wilczek H. Survival of patients who have been on a waiting list for renal transplantation. Nephrol Dial Transplant 2000; 15: 701–704.Google Scholar
  10. 10.
    Port KF, Wolfe RA, Mauger EA, Berling DP, Jiang K. Comparison of survival probabilities for dialysis patients versus cadaveric renal transplant recipients. J Am Med Assoc 1993; 270: 1339–1343.Google Scholar
  11. 11.
    Laupacis A, Keown P, Pus N, et al. A study of the quality of life and cost utility of renal transplantation. Kidney Int 1996; 50: 235–242.Google Scholar
  12. 12.
    Karlberg I, Nyberg G. Cost-effectiveness studies of renal transplantation. Int J Technol Assess Health Care 1995; 11: 611–622.Google Scholar
  13. 13.
    De Witt GA, Ramsteijn PG, De Charro FT. Economic evaluation of end stage renal disease treatment. Health Policy 1998; 44: 215–232.Google Scholar
  14. 14.
    Dew MA, Switzer GE, Goycoolea, et al. Does transplantation produce quality of life benefits? Transplantation 1997; 64: 1261–1273.Google Scholar
  15. 15.
    Franke GH, Heemann U, Kohnle M, Luetkes P, Maehner N, Reimer J. Quality of life in patients before and after kidney transplantation. Psychol Health 2000; 14: 1037–1049.Google Scholar
  16. 16.
    Gudex CM. Health-related quality of life in endstage renal failure. Qual Life Res 1995; 4: 359–366.Google Scholar
  17. 17.
    Shield III CF, McGrath MM, Goss TF for the FK506 kidney transplant study group. Assessment of health-related quality of life in kidney transplant patients receiving tacrolimus (FK506)-based versus cyclosporine-based immunosuppression. Transplantation 1997; 64: 1738–1743.Google Scholar
  18. 18.
    Rebollo P, Ortega F, Baltar JM, et al. Health related quality of life (HRQOL) of kidney transplanted patients: Variables that influence it. Clin Transplant 2000; 14: 199–207.Google Scholar
  19. 19.
    Wight JP, Edwards L, Brazier J, Walters S, Payne JN, Brown CB. The SF-36 as an outcome measure of services for end stage renal failure. Qual Health Care 1998; 7: 209–221.Google Scholar
  20. 20.
    Frazier PA, Davis-Ali SH, Dahl KE. Stressors, social support, and adjustment in kidney transplant patients and their spouses. Soc Work Health Care 1995; 21: 93–108.Google Scholar
  21. 21.
    Derogatis LR, Melisaratos N. The Brief Symptom Inventory: An introductory report. Psychol Med 1983; 13: 595–605.Google Scholar
  22. 22.
    Levy NB, Blumenfield M, Beasley CM, et al. Fluoxetine in depressed patients with renal failure and in depressed patients with normal kidney function. Gen Hosp Psychiatry 1996; 18: 8–13.Google Scholar
  23. 23.
    Sayag R, Kaplan De-Nour A, Shapira Z, Kahan E, Boner G. Comparison of psychosocial adjustment of male non-diabetic kidney transplant and hospital hemodialysis patients. Nephron 1990; 54: 214–218.Google Scholar
  24. 24.
    Soskolne V, De-Nour AK. The psychosocial adjustment of patients and spouses to dialysis treatment. Soc Sci Med 1989; 29: 497–502.Google Scholar
  25. 25.
    Franke GH. Psychometric evaluation of the Social Support Questionnaire (German). Zeitschrift für Medizinische Psychologie 1994; 3: 168–177.Google Scholar
  26. 26.
    Fydrich F, Geyer M, Hessel A, Sommer G, Braehler E. Social supprt questionnaire (F-SozU): Norms of a representative sample (German). Diagnostica 1999; 45: 212–216.Google Scholar
  27. 27.
    Franke GH. First studies about the quality of the Brief Symptom Inventory (BSI) (German). Zeitschrift für Medizinische Psychologie 1997; 6: 159–166.Google Scholar
  28. 28.
    Franke GH. German Manual of the Brief Symptom Inventory of L.R. Derogatis-BSI-(German). Goettingen: Hogrefe, 2000.Google Scholar
  29. 29.
    Derogatis LR. SCL-90-R, Administration, Scoring & Procedures Manual-II for the R(evised) Version and Other Instruments of the Psychopathology Rating Scale Series. Townson: Clinical Psychometric Research, Inc. 1992.Google Scholar
  30. 30.
    Franke GH. German Manual of the Symptom Checklist of L.R. Derogatis-SCL-90-R-(German). Goettingen: Beltz, 1995.Google Scholar
  31. 31.
    Schmitz N, Hartkamp N, Franke GH. Assessing clinically significant change application to the SCL-90-R. Psychol Rep 2000; 86: 263–274.Google Scholar
  32. 32.
    Schmitz N, Hartkamp N, Kruse J, Franke GH, Reister G, Tress W. The Symptom Check-List-90-R (SCL-90-R): A German validation study. Qual Life Res 2000; 9: 185–193.Google Scholar
  33. 33.
    Bullinger M, Kirchberger I. SF-36. German Manual (German). Goettingen: Hogrefe, 1998.Google Scholar
  34. 34.
    Ware JE, Sherbourne CD. The MOS 36-item short form health survey (SF-36). Med Care 1992; 30: 473–483.Google Scholar
  35. 35.
    Franke GH, Reimer J, Kohnle M, Luetkes P, Maehner N, Heemann U. Quality of life in end-stage renal disease patients after successful kidney transplantation: Development of the ESRD Symptom Checklist-Transplantation Module. Nephron 1999; 83: 31–39.Google Scholar
  36. 36.
    Franke GH, Reimer J, Luetkes P, et al. Presentation of a psychodiagnostic inventory measuring disease-specific quality of life in kidney transplant recipients (German). Nieren-und Hochdruckkrankheiten 2000; 29: 233–244.Google Scholar
  37. 37.
    Raboud JM, Singer J, Thorne A, Schechter MT, Shafran SD. Estimating the effect of treatment on quality of life in the presence of missing data due to drop-out and death. Qual Life Res 1998; 7: 487–494.Google Scholar
  38. 38.
    DeOreo PB. Hemodialysis patients-assessed functional health status predicts continued survival, hospitalization, and dialysis-attendance compliance. Am J Kidney Dis 1997; 30: 204–212.Google Scholar
  39. 39.
    Singer MA, Hopman WM, Mac Kenzie TA. Physical functioning and mental health in patients with chronic medical conditions. Qual Life Res 1999; 8: 687–691.Google Scholar
  40. 40.
    de Leval N. Scales of depression, ill-being and the quality of life-is there any difference? An assay in taxonomy. Qual Life Res 1995; 4: 259–269.Google Scholar
  41. 41.
    Burton HJ, Kline SA, Lindsay RM, Heidenheim P. The role of support in influencing outcome of end-stage renal disease. Gen Hosp Psychiatry 1988; 10: 260–266.Google Scholar

Copyright information

© Kluwer Academic Publishers 2003

Authors and Affiliations

  • Gabriele Helga Franke
    • 1
  • Jens Reimer
    • 2
  • Thomas Philipp
    • 3
  • Uwe Heemann
    • 3
  1. 1.Psychology of RehabilitationUniversity of Applied SciencesMagdeburg and StendalGermany
  2. 2.Department of PsychiatryUniversity of HamburgGermany
  3. 3.Department of Nephrology, Center for Internal MedicineUniversity of EssenGermany

Personalised recommendations